Use of calcium channel blockers and breast carcinoma risk in postmenopausal women

Cancer

Volumn 80, Issue 8, 1997, Pages 1438-1447

  Fitzpatrick, Annette L ^a   Daling, Janet R ^a   Furberg, Curt D ^b   Kronmal, Richard A ^a   Weissfeld, Joel L ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Antihypertensives; Apoptosis; Breast carcinoma; Calcium channel blockers

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT;

AGED; ARTICLE; BREAST CARCINOMA; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RISK; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL;

AGE FACTORS; AGED; BREAST NEOPLASMS; CALCIUM CHANNEL BLOCKERS; COHORT STUDIES; ESTROGENS; FEMALE; HUMANS; POSTMENOPAUSE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 0030826328     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19971015)80:8<1438::AID-CNCR11>3.0.CO;2-6     Document Type: Article

References (41)

1. Wyllie AH. Apoptosis (the 1992 Frank Rose Memorial Lecture). Br J Cancer 1993; 67:205-8.
2. Cohen JJ. Apoptosis. Immunol Today 1993; 14:125-30.
3. Stewart BW. Mechanisms of apoptosis: integration of genetic, biochemical and cellular indicators. J Natl Cancer Inst 1994; 86:1286-96.
4. Sen S. Programmed cell death: concept, mechanism and control. Biol Rev Camb Philos Soc 1992; 67:287-319.
5. Trauth BC, Klas C, Peters AMJ, Matzku S, Moller P, Falk W, et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989;245:310-5.
6. 2+-dependent endonuclease activation is an early event in VP-16-induced apoptosis of human breast cancer MCF7 cells in vitro. Biochim Biophys Acta 1995; 1266:135-42.
7. Pahor M, Guralnik JM, Ferrucci L, Corti M-C, Salive ME, Cerhan JR, et al. Calcium-channel blockade and incidence of cancer in aged population. Lancet 1996; 348:493-7.
8. Strange R, Friis RR, Bemis LT, Geske FJ. Programmed cell death during mammary gland involution. Methods Cell Biol 1995; 46:355-68.
9. Fried LP, Borhani NO, Enright PE, Furberg CD, Gardin JM, Kronmal RA, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1991; 1:263-76.
10. Tell GS, Fried LP, Hermanson B, Manolio TA, Newman AB, Borhani NO. Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. Ann Epidemiol 1993; 3:358-66.
11. Psaty BM, Lee M, Savage PJ, Rutan GH, German PS, Lyles M. Assessing the use of medications in the elderly: methods and initial experience in the Cardiovascular Health Study. J Clin Epidemiol 1992; 45:683-92.
12. Ives DG, Fitzpatrick AL, Bild DE, Psaty BM, Kuller LH, Crowley PM, et al. Surveillance and ascertainment of cardiovascular events: the Cardiovascular Health Study. Ann Epidemiol 1995; 5:278-85.
13. Opie LH. Calcium channel antagonists (calcium entry blockers). In: Opie LH, editor. Drugs for the heart. 3rd edition. Philadelphia: W.B. Saunders, 1991:42-73.
14. Norusis MJ, SPSS Inc. SPSS for Windows: advanced statistics. Release 6.0. Chicago, IL: SPSS Inc., 1993.
15. Marubini E, Valsecchi MG. Analyzing survival data from clinical trials and observational studies. New York: John Wiley and Sons, 1995.
16. Kronmal RA. Spurious correlation and the fallacy of the ratio standard revisited. J Roy Stat Soc (A) 1993; 156(Part III):379-92.
17. Franceschi S, la Vecchia C, Negri E, Parazzini F, Boyle P. Breast cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer 1990; 26:781-5.
18. Tornberg SA, Holm L-E, Carstensen JM. Breast cancer risk in relation to serum cholesterol, serum beta-lipoprotein, height, weight and blood pressure. Acta Oncol 1988; 27:31-7.
19. Manolio TA, Cutler JA, Furberg CD, Psaty BM, Whelton PK, Applegate WB. Trends in pharmacologic management of hypertension in the United States. Arch Intern Med 1995; 155: 829-37.
20. 2+ concentration. Arch Biochem Biophys 1989; 269:365-70.
21. Tenniswood MP, Guenette RS, Lakins J, Mooibroek M, Wong P, Welsh JE. Active cell death (ACD) in hormone-dependent tissues. Cancer Metastasis Rev 1992; 11:197-200.
22. Ferguson DJ. An ultrastructural study of mitosis and cytokinesis in normal 'resting' human breast. Cell Tissue Res 1988; 252:581-7.
23. Marti A, Jehn B, Costello E, Keon N, Ke G, Martin F, et al. Protein kinase A and AP-1 (cFos/JunD) are induced during apoptosis of mouse mammary epithelial cells. Oncogene 1994; 9:1213-23.
24. Schulte-Hermann R, Bursch W, Grasl-Kraupp B, Torok L, Ellinger A, Mullauer L. Role of active cell death (apoptosis) in multi-stage carcinogenesis. Toxicol Lett 1995; 82/83:143-8.
25. Ishida H, Kondoh T, Kataoka M, Nishikawa S, Nakagawa T, Morisaki I, et al. Factors influencing nifedipine-induced gingival overgrowth in rats. J Periodontol 1995; 66:345-50.
26. Correale P, Tagliaferri P, Celio L, Genua G, Mantagnani S, Bianco AR. Verapamil upregulates sensitivity of human colon an breast cancer cells to LAK-cytotoxicity in vitro. Eur J Cancer 1991; 27:1383-95.
27. El Azzouzi B, Tsangaris GT, Pellegrini O, Manuel Y, Benveniste J, Thomas Y. Cadmium induces apoptosis in human T cell line. Toxicology 1994; 88:127-39.
28. Sato K, Ishizuka J, Cooper CW, Chung DH, Tsuchiya T, Uchida T, et al. Inhibitory effect of calcium channel blockers on growth of pancreatic cancer cells. Pancreas 1994; 9:193-202.
29. Sugimoto K, Simard J, Haagensen DE, Labrie F. Inverse relationships between cell proliferations and basal or androgen-stimulated apolipoprotein D secretion in LNCaP human prostate cancer cells. J Steroid Biochem Mol Biol 1994; 51: 167-74.
30. Taylor JM, Simpson RU. Inhibition of cancer cell growth by calcium channel antagonists in the athymic mouse. Cancer Res 1992; 52:2413-8.
31. Kondo S, Yin D, Morimura T, Takeuchi J. Combination therapy with cisplatin and nifedipine inducing apoptosis in multi-drug-resistant human glioblastoma cells. J Neurosurg 1995; 82:469-74.
32. Cole K, Kohn E. Calcium-mediated signal transduction: biology, biochemistry, and therapy. Cancer Metastasis Rev 1994; 13:31-44.
33. Wang TT, Phang JM. Effects of estrogen on apoptotic pathways in human breast cancer cell one MCF-7. Cancer Res 1995; 55:2487-9.
34. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68:251-300.
35. Warri AM, Huovinen RL, Laine AM, Martikainen PM, Harkonen PL. Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro. J Natl Cancer Inst 1993; 85:1412-8.
36. Tanner LA, Bosco LA. Gynecomastia associated with calcium channel blocker therapy. Arch Intern Med 1988; 148:379-80.
37. Boyd IW. Adverse Drug Reaction Advisory Committee. Gynecomastia in association with calcium antagonists. Med J Aust 1994; 161:328.
38. Pahor M, Guralnik JM, Salive ME, Corti M-C, Carbonin P, Havlik R. Do calcium channel blockers increase the risk of cancer? Am J Hypertens 1996; 9:695-9.
39. Jick H, Jick S, Derby LE, Vasilakis C, Myers MW, Meier CR. Calcium-channel blockers and risk of cancer. Lancet 1997; 349:525-8.
40. Pahor M, Guralnik JM, Corti M-C, Foley DJ, Carbonin P, Havlik RJ. Long-term survival and use of antihypertensive medications in older persons. J Am Geriatr Soc 1995;43:1191-7.
41. Furberg CD, Psaty BM, Meyer JV. Nifedipine dose-related increase in mortality in patients with coronary heart disease. Circulation 1995; 92:1326-31.